Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by MrMugsyon Jun 07, 2022 2:36pm
227 Views
Post# 34737832

It's unfortunate ...

It's unfortunate ...But we've got an opportunity to give Doctor's more tools for the toolbox !

There's an old adage among physicians that "the patient can always hurt you more." This refers to the emotional toll personal mistakes and surgical complications can have on physicians when treating ill patients. A recent event has given that old adage a new, more tangible meaning.

Michael Louis, a patient at a Tulsa, Oklahoma, medical office, underwent spinal surgery last month. After being released on May 24, he repeatedly called the clinic to get further treatment for his lasting pain to no avail. On June 2, he targeted and killed his surgeon, Preston Phillips, before killing himself in a mass shooting.

While this story is shocking, it is not unpredictable. Doctors are often threatened by patients in immense pain after they are abruptly cut off from their opioid medications. How did we get here? 

https://reason.com/2022/06/07/americas-failed-opioid-policy-drove-the-tulsa-shooter-to-violence/

<< Previous
Bullboard Posts
Next >>